Asahi Kasei Pharma Applies for Approval of Famvir for Additional Indication
(Feb 7, 2012)
Asahi Kasei Pharma Launches Flivas in South Korea
(Jan 13, 2012)
Asahi Kasei Pharma Launches Osteoporosis Drug in Japan
(Dec 6, 2011)
Artisan Pharma Now Wholly Owned Subsidiary of Asahi Kasei
(Nov 9, 2011)
Asahi Kasei to Build New Pharmaceutical Research Complex
(Nov 4, 2011)
Asahi Kasei Licenses Zosano Pharma Microprojection Technology for Teribone Hormone
(Oct 17, 2011)
Asahi Kasei Pharma Licenses XIAFLEX from Auxilium Pharmaceuticals
(Mar 23, 2011)
Asahi Kasei Targets Osteoporosis in Japan
(Oct 26, 2010)
Asahi Kasei Pharma Licenses Bisphosphonate Zoledronic Acid for Japan
(June 15, 2010)
Asahi Kasei Licenses Anti-glaucoma Drug to Altheos
(Apr 9, 2010)
| 
